Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions

被引:2
|
作者
Hamed, Sherifa A. [1 ]
机构
[1] Assiut Univ Hosp, Hosp Neurol & Psychiat, Dept Neurol & Psychiat, Assiut 71516, Egypt
关键词
Tumefactive multiple sclerosis; Acute dementia;
D O I
10.12998/wjcc.v3.i6.525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe an unusual clinical and diagnostic feature of a patient with multiple sclerosis (MS). A 25-yearold woman was admitted to the Neurology department (December 2009) with one month history of rapid cognitive deterioration. She had poor cognition, dysphasia, reduction in visual acuity and temporal pallor of the optic discs. She had prolonged latencies of P100 component of visual evoked potentials (VEPs). Magnetic resonance imaging (MRI)-brain showed multifocal large (>= 3 cm) white-matter hypointense lesions in T1W and hyperintense in T2W and fluid-attenuated inversion recovery images and patchy enhancement. A diagnosis of tumefactive MS was given. She received two consecutive 5-d courses of 1 g daily intravenous methylprednisolone for 2 mo and oral prednisolone in dose of 80 mg twice/ daily in between. At the 3rd month, Mini Mental State Examination and VEPs returned to normal but not the MRI. Patient continued oral steroids after hospital discharge (March 2010) for 9 mo with significant MRI improvement after which tapering of steroids started for a year. The patient refused immunomodulation therapy due to her low socioeconomic status. Neither clinical relapse nor new MRI lesions were observed throughout the next 4 years. In spite of the aggressive course of tumefactive MS variant, good prognosis may be seen in some patients.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 50 条
  • [2] Tumefactive Demyelinating Lesions in Multiple Sclerosis
    Tamas, Olivera
    Kovacevic, Marija
    Saranovic, Jelena
    Veselinovic, Nikola
    Budimkic, Maja
    Jovicevic, Vanja
    Momcilovic, Nikola
    Andabaka, Marko
    Vitkovic, Jelena
    Mesaros, Sarlota
    Drulovic, Jelena
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 689 - 689
  • [3] Prevalence of tumefactive demyelinating lesions in multiple sclerosis
    Totaro, R.
    Splendiani, A.
    Di Carmine, C.
    Torlone, S.
    Patriarca, L.
    Marini, C.
    Carolei, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 389 - 389
  • [4] Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions
    Kizek, Ozgu
    Dogan, Faruk Ugur
    Gunduz, Tuncay
    Kurtuncu, Murat
    Eraksoy, Mefkure
    NEUROLOGY, 2020, 94 (15)
  • [5] Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders
    Meredith C. Frederick
    Michelle H. Cameron
    Current Neurology and Neuroscience Reports, 2016, 16
  • [6] Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders
    Frederick, Meredith C.
    Cameron, Michelle H.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (03) : 1 - 7
  • [7] Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis
    Zhang, Y.
    Metz, L. M.
    NEUROLOGY, 2010, 75 (15) : 1396 - 1396
  • [8] Tumefactive multiple sclerosis or inflammatory demyelinating disease with large lesions?
    Lassmann, Hans
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (03) : 687 - 688
  • [9] Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab
    Moghadasi, Abdorreza Naser
    Baghbanian, Seyed Mohammad
    ACTA NEUROLOGICA BELGICA, 2019, 119 (01) : 137 - 139
  • [10] Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis
    Azzimonti, Matteo
    Margoni, Monica
    Zanetta, Chiara
    Genovese, Federica
    Martinelli, Vittorio
    Rocca, Maria A.
    Baldoli, Cristina
    Moiola, Lucia
    Filippi, Massimo
    JOURNAL OF NEUROLOGY, 2024, 271 (04) : 1663 - 1667